Welcome to this week's Chutes and Ladders, our roundup of hirings and firings throughout the industry. Please send the good word--or the bad--from your shop to Michael Gibney (email | Twitter) or Emily Mullin (email | Twitter) and we will feature it here at the end of each week.
Former investment banker tapped as new Shire chairwoman
Shire ($SHPG) CEO Flemming Ornskov has tapped Susan Kilsby to be the company's chairwoman. She will replace Matthew Emmens, Shire's former CEO and chairman since 2008, who is retiring. Kilsby, a former investment banker, joined the Shire board as a nonexecutive director in September 2011. Story
|
||||||||||||
Pharma
> Vivus ($VVUS) CFO Timothy Morris is stepping down. The company's controller, Svai Sanford, will fill the position on an interim basis. Story
> NextPharma Technologies appointed Eric Bertrand as the head of its liquids arm in Limay, France; Ralf Blesel as the head of its penicillin branch in Berlin; and Nigel Cryer as vice president of quality and regulatory functions. Release
> Alacrita named Pierre Dodion an associate partner. Release
Biotech
> Dr. Justin Klamerus has been named chief quality officer and executive vice president of community-based programs for the Barbara Ann Karmanos Cancer Institute. Release
> Dr. Mahmoud Ghazzi joined Daiichi Sankyo as the company's global head of drug development. Release
> Spark Therapeutics has named Dr. Rogerio Vivaldi, formerly the senior vice president and head of rare diseases at Genzyme, as its first independent board member. Release
> Keryx Biopharmaceuticals ($KERX) has appointed Daniel Olmstead to the newly created position of vice president of payer access. Release
> The Illinois Biotechnology Industry Organization has elected Andy Hull as chairman of the iBIO board of directors and Linda Friedman as chairperson of the iBIO Institute board of directors. Release
> Ryan Daws was appointed chief financial officer of Concert Pharmaceuticals. Release
> Curtis Carlson, CEO and president of SRI International, is retiring after 16 years in the position and 40 years of service with the organization. Release
> PTC Therapeutics ($PTCT) has appointed Dr. Robert Spiegel chief medical officer and Murad Husain vice president of global regulatory affairs. Release
> Imugene appointed Christoph Zielinski and Dr. Ursula Wiedermann to its scientific advisory board. Release
> Emerson Ecologics brought Corey Schuler and Diana Noland onto its practitioner advisory council. Release
> Autonomic Technologies appointed Dr. Shashidhar Kori as its chief medical officer. Release
> Advanced Cell Technology's CEO Gary Rabin left his position abruptly, and CFO Edward Myles will act as interim until a replacement is found. Release
> Former FDA commissioner Dr. Andrew von Eschenbach and former Deputy Assistant Secretary of Treasury Wesley Yin joined healthcare consulting company Precision Health Economics. Release
CRO
> Icon ($ICLR) named Dariush Elahi as the company's head of metabolic research. Release
> Asli Turkes and Susan Timoney joined INC Research's oncology team as vice president of clinical development and executive director of clinical development, respectively. Release